Northwestern Medicine Genitourinary Cancer Care
Cancers of the prostate, bladder, testes, and kidney are all fairly common, which makes early detection, diagnosis and screening very important for effective treatment.
Northwestern Medicine’s team of genitourinary specialists have leading expertise in the diagnosis, study, and treatment of cancers of the prostate, bladder, testes, and kidney.
Request Appointment, Find Doctors or Contact Us
Genitourinary cancer includes cancers that involve the reproductive and urinary system, such as:
- Prostate cancer
- Bladder cancer
- Kidney cancer
- Testicular cancer
Prostate cancer is the second leading cause of cancer-related death in men in the United States, but treatment may be determined by a urologist based on the severity of the disease. In the United States, there are an estimated 72,570 new cases of bladder cancer each year, affecting mostly older men and women.
An experienced urologist can help with both diagnosis and treatment of these forms of cancer.
Cancer Care Centers
Battling cancer is a multistep journey that may require many visits. During treatment, you need to devote your energy to getting healthy, not getting to the next appointment. That’s why treatment and support services at Northwestern Medicine are conveniently located throughout Chicago and the surrounding suburbs, so you can get quick access to all the expertise and support you need, close to home.
Why choose NM for your Cancer Care
Patients with cancers of the prostate, bladder, kidney, testis, and related organs are evaluated and managed with emphasis on an integrated, multidisciplinary and stage-specific approach. All of the team members are recognized leaders in their field of expertise, and all potential therapeutic options are considered and discussed with each patient, including:
- Observation (no active treatment
- Surgical excision
- Radiation therapy
- Chemotherapy
- Immunotherapy
Management options are discussed each week at our urologic oncology patient management conference, allowing for additional critical input and crystallization of the treatment plan.
